Pierre Fabre Group is a multinational pharmaceutical and cosmetics company based in Castres, France, near Toulouse. The Group had a consolidated turnover of 1.43 billion euros ($1.62 billion) in 2003 (including 44% international).
Founded in 1961 by Pierre Fabre, it is present in over 130 countries and has more than 9,000 employees (in 2003), 34% of whom are internationally-based. Activity of the Group is focused on research, development, manufacturing and marketing of skin cosmetics, prescription medicines and family health products. Pharmacy represents 50% of turnover, dermo-cosmetics represent 42%, and homeopathy-phytotherapy 8% (percentages of 2003 turnover).
Pierre Fabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid class.
External link
Pierre Fabre Group (http://www.pierre-fabre.com/front/homepage/0,2135,2072_0_0_en_US,00.html) - Official site
He said that there were plenty of successful companies wanting to work with PierreFabre to help it exploit its rich research and development pipeline and that, as long as this remained the case, the company would continue to stand aside from the current spate of merger and acquisition activity.
The collaboration between PierreFabre and the CNRS is a long and important one.
PierreFabre has circumvented this problem by the use of superacidic chemistry, which involves reacting vinca alkaloids with a mixture of a Lewis acid and hydrogen fluoride in a Teflon reaction vessel.
Laboratoires PierreFabre is a multinational pharmaceutical and cosmetics company based in Castres, France, near Toulouse.
Founded in 1961 by PierreFabre, it is present in over 130 countries and has more than 9,000 employees (in 2003), 34% of whom are internationally-based.
PierreFabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid class.
Feeds |
Contact